Cedars-Sinai Medical Center clinical trial pipeline
Data updated daily from ClinicalTrials.gov, last refresh 2026-11-19
What changed in the last 30 days
15 trials changed in the last 30 days: 1 stopped, 8 with notable changes, 6 with minor changes only.
- Notable: WARRIOR · Women's IschemiA TRial to Reduce Events In Non-ObstRuctive CAD Primary completion pushed from May 31, 2024 to Feb 15, 2025
- Notable: Online Pain Education for Crohn's Disease and Ulcerative Colitis Enrolling by invitation only
- Minor: Neoadjuvant Radiosurgery · Metastatic Brain Tumors Study completion pushed from Jun 1, 2026 to Sep 1, 2027
- Notable: Digital Inhaler Use in Obstructive Lung Disease Care Recruitment opened
- Minor: Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes Primary completion pushed from Jan 1, 2027 to Mar 31, 2027
- Notable: SAMe · Oxaliplatin-associated Liver Injury Primary and study completion pushed from Oct 2028 to Jan 2030
- Minor: Impact of Protect Your Colon™ on CRC Screening Trial completed
- Notable: Intraoperative Imaging of Gastrointestinal Malignancies Using Pafolacianine (CYTALUX™) Primary completion pushed from Aug 2026 to Aug 31, 2027
- Minor: Time-Restricted Eating and Cancer: Clinical Outcomes, Mechanisms, and Moderators Trial completed
- Stopped: Ostomy Readmission Reduction Program Withdrawn before enrolling
- Notable: LEAPTogether · Intergenerational Intervention to Address Loneliness and Social Isolation Primary completion date changed from estimate of May 2025 to Mar 25, 2026
- Notable: ERSIAS IIb · EDAS Revascularization for Symptomatic Intracranial Atherosclerotic Steno-occlusive Disease Primary endpoint(s) modified
- Minor: Longitudinal Changes in Donor-Derived Cell-Free DNA With Tocilizumab Treatment for Chronic Antibody-Mediated Rejection Trial completed
- Notable: SIBO in PDAC · Small Intestinal Bacterial Overgrowth (SIBO) in Pancreatic Adenocarcinoma (PDAC) Primary and study completion pushed from Apr 14, 2026 to Oct 14, 2028
- Minor: Novel Multiplex ELISA Assay for Evaluating · Gross Hematuria for Bladder Cancer Trial completed
- Stopped: terminated, suspended or withdrawn
- Notable: the plan changed
- Minor: routine updates
New trial filings, last 30 days
| First posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-11-13 | NCT07935161 Steps to Extend Latency in Preterm Prelabor Rupture of Membranes | Not Yet Recruiting | |
| 2026-10-27 | NCT07896499 Geko™ Device in Prevention of Pain and Swelling Following Knee Arthroscopy | Phase 4 | Not Yet Recruiting |
| 2026-10-22 | NCT07889063 Artificial Intelligence (AI)-Initiated Clinical Decision Support in Hospitalist Practice | Not Yet Recruiting |
Active trials by phase
| Early Phase 1 | 4 | |
| Phase 1 | 5 | |
| Phase 1/2 | 2 | |
| Phase 2 | 16 | |
| Phase 2/3 | 3 | |
| Phase 3 | 1 | |
| Phase 4 | 5 |
Not charted: 81 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).
Disease areas by active trials, top 10 of 41
Heart Disease (17) · Bladder Cancer (5) · Heart Failure (5) · Obesity (5) · Anxiety (4) · Epilepsy (4) · Head & Neck Cancer (4) · Parkinson's Disease (4) · Prostate Cancer (4) · Breast Cancer (3)
Get alerts when Cedars-Sinai Medical Center's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.